Skip to content

Role of lipid emulsion in organophosphate compound poisoning

To Study the Effects of Extended Doses of Lipid Emulsion in Organophosphate Compound Poisoning: Randomised Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018699
Enrollment
40
Registered
2019-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticides

Interventions

Intervention1: 20% intralipid emulsion: bolus dose of 20% lipid emulsion 100ml over 1 hour followed by 20% lipid emulsion 100ml over 6 hours Control Intervention1: Normal Saline: 100ml of NS over 1 ho

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. History of consumption of organophosphate compound. 2. Clinical manifestations of moderate or severe organophosphorus compound poisoning as per Peradeniya Severity Score. 3. Informed consent from the patient or next kin.

Exclusion criteria

Exclusion criteria: 1. Where the compound ingested could not be identified. 2. History of combined poisoning with a non-OP compound. 3. All other patients not fitting in the organophosphate symptom complex. 4. Patients having underlying kidney and liver ailments. 5. History suggestive of acute pancreatitis in the past.

Design outcomes

Primary

MeasureTime frame
To study the change in amount of atropine dose used after delivering extended doses of lipid emulsion in OP poisoned individuals. In test arm we will give 20% of 100ml Lipid emulsion over 1 hour followed by an infusion of the same over 6 hours. In control arm we will give 100ml of NS over 1 hour followed by 100ml NS over 6 hours.Timepoint: After 48 hours total dose of atropine required will be calculated

Secondary

MeasureTime frame
1. Hemodynamic parameters (pulse rate, systolic, diastolic blood pressures, mean arterial pressure and respiratory rate) 2. Duration of hospitalization 3. Duration of mechanical ventilation required 4. In-hospital 7 days mortality 5. 28th day mortality Timepoint: At 0 hour, 6 hours, 24 hours and 48 hours

Countries

India

Contacts

Public ContactSahil

PGIMER

bhalla.chd@gmail.com9914209536

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026